1. Introduction {#s0005}
===============

Heavy metals are the most consistent pollutants of present environment due to their non-biodegradable nature and high bioaccumulation potential ([@b0065]). Cadmium is a widespread industrial and environmental pollutant that may cause adverse effects on human beings and animals. Major anthropogenic sources of cadmium exposure to human are mining, electrodes of rechargeable batteries, alloys production, tobacco smoking, electroplating, plastic stabilizers, vapor lamps, engraving, fertilizers and old galvanized PVC water supply pipes ([@b0025], [@b0085]). In Present Scenario discarded electronic materials and their components have arisen as the biggest source of Cadmium exposure.

Cadmium from various sources percolates through the ground and approaches the drinking water, thus directly enters to food-chain. Oral exposure leads cadmium to liver and kidneys for further metabolism and excretion. Thus kidneys are the primary organ inside the body to encounter with cadmium load. Long term chronic exposure of cadmium many result in severe kidney damage to renal failure ([@b0040]). Renal damage primarily alters the filtration rate, thus impaired renal functions could be measured by serum level of nitrogenous waste and proteins. Although endogenous protection mechanism of body overcomes these damages to a vary extent, but it might not be sufficient enough for overflown limits of cadmium exposure. In this study we have tried to establish *Catharanthus roseus* extract to provide exogenous supplement against nephrotoxicity of cadmium.

*Catharanthus roseus*, the *Madagascar periwinkle* or common Sadabahar is a perennial herb of family Apocynaceae. Besides its ornamented value, this plant is known to have a number of pharmacological actions of clinical importance like anti-inflammatory, antioxidant and anti-carcinogenetic properties ([@b0015], [@b0095]). Chemically, *Catharanthus roseus* pertains over hundred different terpenoid indole alkaloids (TIAs) ([@b0070]) among which vinblastine and vincristine are well know clinically used anti-carcinogenic alkaloids ([@b0050]).

2. Material and methods {#s0010}
=======================

Eighty adult male albino rats (*Rattus norvegicus*) of wistar strain were selected from inbred colony. All the rats were of almost same age and weight (100 ± 10 gm). They were acclimatized at room temperature with 12 h dark/light cycle, fed on standard diet and water *ad-libitum.* The rats were maintained as per latest guidelines of Committee for the Purpose of Controls and Supervision of Experiments on Animals (CPCSEA-2018).

Test Compound was cadmium chloride of analytical grade purity, purchased from Merck, India. The LD50 of cadmium chloride for albino rats were determined by log dose/probit regression line method ([@b0035]) and it was found to be 88 mg/kg body weight. Further sub lethal doses were calculated by standard method.

Experimental plant, *Catharanthus roseus* was grown in garden associated to our laboratory and methanolic extract was prepared from all aerial parts. The extract was analyzed for its chemical ingredient through GC/MS with the help of ThermoFischer ISQ 7000 instrument. Further safety trail was performed to determine the dose of extract and set it to be 500 mg/kg body weight.

For experimentation all rats were grouped in to four sets one acute (1d) and there sub-acute (7, 14, 21 ds). Each set contain four groups one control (group-A) and three treated (group B, C, and D). Details of doses to various group has been shown in [Table 1](#t0005){ref-type="table"}.Table 1Acute & sub-acute doses of cadmium chloride and *Catharanthus roseus* for *Rattus norvegicus.*SetsGroupsGroup-A (Control)Group-B (Cadmium treated)Group-C (Catharanthus treated)Group-D (Catharanthus + cadmium treated)Set: I Acute (1 day)Water8.8 mg/kg body weight500 mg/kg body weight500 mg/kg body weight (*C. roseus*) + 8.8 mg/kg body weight (Cd)Set: II Sub-acute (7 days)Water1.26 mg/kg body weight500 mg/kg body weight500 mg/kg body weight (*C. roseus*) + 1.26 mg/kg body weight (Cd)Set: III Sub-acute (14 days)Water0.63 mg/kg body weight500 mg/kg body weight500 mg/kg body weight (*C. roseus*) + 0.63 mg/kg body weight (Cd)Set: IV Sub-acute (21 days)Water0.42 mg/kg body weight500 mg/kg body weight500 mg/kg body weight (*C. roseus*) + 0.42 mg/kg body weight (Cd)

At the end of designated days, rats of various groups were sacrificed and blood samples were collected from the ventricle of heart. Serum was separated for determination of Urea and BUN by Berthelot Method ([@b0075]), Serum uric acid by Uricase Trinder Method ([@b0075]), Serum creatinine by Alkaline Picrate Method ([@b0090]) and protein profile by modified Biuret assay method ([@b0030]). The results were validated by histological study of kidneys.

The observations were analyzed statistically using analysis of variance (ANOVA) followed by Student's Newmann Keul's (SNK) test. The obtained values were compared to control and signified at the level of p \< 0.01.

3. Result {#s0015}
=========

Results of the study have been summarized in [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}, showing that cadmium intoxication significantly enhances the serum level of nitrogenous wastes (urea, BUN, Uric Acid and Creatinin) while decreases the serum proteins in acute and Sub-acute sets both. This altered level of nitrogenous wastes and serum proteins are brought back to normalcy by pretreatment with *Catharanthus roseus* extract, observed as non-significant result of group-D compared to control. Whereas *C*. *roseus* itself does not produce any harmful effect, again observed as non-significant results of Group-C as compared to control. For validation of amelioration histology was performed for all group of sub-acute sets (21 days), which is shown as [Fig. 1](#f0005){ref-type="fig"}A--D.Table 2Serum nitrogenous wastes concentration (mg/dL) in albino rat treated with *Catharanthus roseus* followed by cadmium chloride (values are expressed as Mean ± SEM).Serum nitrogenous wasteTreatment daysControlCadmium treatedCatharanthus treatedCatharanthus + Cadmium treatedUrea (mg/dL)Acute (1 day)17.42 ± 0.1219.84 ± 0.62[\*](#tb1fn1){ref-type="table-fn"}17.19 ± 0.18[ns](#tb2fn2){ref-type="table-fn"}17.56 ± 0.07[\*](#tb1fn1){ref-type="table-fn"}Sub-acute (7 days)16.56 ± 0.1520.83 ± 0.34[\*](#tb1fn1){ref-type="table-fn"}17.26 ± 0.57[ns](#tb2fn2){ref-type="table-fn"}17.58 ± 0.12[ns](#tb2fn2){ref-type="table-fn"}Sub-acute (14 days)17.72 ± 0.1120.56 ± 0.35[\*](#tb1fn1){ref-type="table-fn"}17.61 ± 0.03[ns](#tb2fn2){ref-type="table-fn"}17.57 ± 0.98[ns](#tb2fn2){ref-type="table-fn"}Sub-acute (21 days)17.37 ± 0.2720.87 ± 0.41[\*](#tb1fn1){ref-type="table-fn"}17.28 ± 0.47[ns](#tb2fn2){ref-type="table-fn"}17.59 ± 0.29[ns](#tb2fn2){ref-type="table-fn"}  BUN (mg/dL)Acute (1 day)6.98 ± 0.089.58 ± 0.16[\*](#tb1fn1){ref-type="table-fn"}7.64 ± 0.08[ns](#tb2fn2){ref-type="table-fn"}8.02 ± 0.16[\*](#tb1fn1){ref-type="table-fn"}Sub-acute (7 days)7.94 ± 0.0410.01 ± 0.13[\*](#tb1fn1){ref-type="table-fn"}7.98 ± 0.53[ns](#tb2fn2){ref-type="table-fn"}8.09 ± 0.9[ns](#tb2fn2){ref-type="table-fn"}Sub-acute (14 days)8.01 ± 0.089.89 ± 0.16[\*](#tb1fn1){ref-type="table-fn"}7.37 ± 0.124[ns](#tb2fn2){ref-type="table-fn"}8.36 ± 0.47[ns](#tb2fn2){ref-type="table-fn"}Sub-acute (21 days)7.64 ± 0.0410.25 ± 0.10[\*](#tb1fn1){ref-type="table-fn"}7.98 ± 0.02[ns](#tb2fn2){ref-type="table-fn"}8.59 ± 0.64[ns](#tb2fn2){ref-type="table-fn"}  Uric acid (mg/dL)Acute (1 day)2.12 ± 0.092.27 ± 0.05[\*](#tb1fn1){ref-type="table-fn"}2.13 ± 0.02[ns](#tb2fn2){ref-type="table-fn"}2.09 ± 0.02[\*](#tb1fn1){ref-type="table-fn"}Sub-acute (7 days)2.09 ± 0.132.28 ± 0.05[\*](#tb1fn1){ref-type="table-fn"}2.19 ± 0.01[ns](#tb2fn2){ref-type="table-fn"}2.09 ± 0.01[ns](#tb2fn2){ref-type="table-fn"}Sub-acute (14 days)2.08 ± 0.082.29 ± 0.06[\*](#tb1fn1){ref-type="table-fn"}2.17 ± 0.03[ns](#tb2fn2){ref-type="table-fn"}2.07 ± 0.04[ns](#tb2fn2){ref-type="table-fn"}Sub-acute (21 days)2.06 ± 0.082.34 ± 0.06[\*](#tb1fn1){ref-type="table-fn"}2.13 ± 0.01[ns](#tb2fn2){ref-type="table-fn"}2.13 ± 0.02[ns](#tb2fn2){ref-type="table-fn"}  Creatinin (mg/dL)Acute (1 day)0.57 ± 0.171.02 ± 0.08[\*](#tb1fn1){ref-type="table-fn"}0.89 ± 0.03[ns](#tb2fn2){ref-type="table-fn"}0.96 ± 0.02[ns](#tb2fn2){ref-type="table-fn"}Sub-acute (7 days)0.63 ± 0.090.99 ± 0.08[\*](#tb1fn1){ref-type="table-fn"}0.88 ± 0.04[ns](#tb2fn2){ref-type="table-fn"}0.98 ± 0.02[ns](#tb2fn2){ref-type="table-fn"}Sub-acute (14 days)0.62 ± 0.080.97 ± 0.05[\*](#tb1fn1){ref-type="table-fn"}0.93 ± 0.07[ns](#tb2fn2){ref-type="table-fn"}0.95 ± 0.01[ns](#tb2fn2){ref-type="table-fn"}Sub-acute (21 days)0.65 ± 0.031.01 ± 0.03[\*](#tb1fn1){ref-type="table-fn"}0.98 ± 0.06[ns](#tb2fn2){ref-type="table-fn"}0.98 ± 0.04[ns](#tb2fn2){ref-type="table-fn"}[^1][^2]Table 3Serum Protein profile (g/dL) in albino rat treated with *Catharanthus roseus* followed by cadmium chloride (values are expressed as Mean ± SEM).Serum proteinsTreatment dayControlCadmium treatedCatharanthus treatedCadmium + Catharanthus treatedTotal Proteins (g/dL)Acute (1 day)7.01 ± 0.026.43 ± 0.02[\*](#tblfn3){ref-type="table-fn"}7.83 ± 0.01[ns](#tblfn4){ref-type="table-fn"}6.78 ± 0.17[\*](#tblfn3){ref-type="table-fn"}Sub-acute (7 days)7.04 ± 0.015.89 ± 0.07[\*](#tblfn3){ref-type="table-fn"}8.29 ± 0.07[ns](#tblfn4){ref-type="table-fn"}6.98 ± 0.48[\*](#tblfn3){ref-type="table-fn"}Sub-acute (14 days)6.98 ± 0.175.16 ± 0.09[\*](#tblfn3){ref-type="table-fn"}7.89 ± 0.23[ns](#tblfn4){ref-type="table-fn"}7.67 ± 0.24[ns](#tblfn4){ref-type="table-fn"}Sub- Acute (14 days)6.94 ± 0.124.51 ± 0.08[\*](#tblfn3){ref-type="table-fn"}7.87 ± 0.09[ns](#tblfn4){ref-type="table-fn"}7.51 ± 0.31[ns](#tblfn4){ref-type="table-fn"}  Albumins (g/dL)Acute (1 day)4.27 ± 0.194.17 ± 0.09[\*](#tblfn3){ref-type="table-fn"}4.68 ± 0.23[ns](#tblfn4){ref-type="table-fn"}4.17 ± 0.09[\*](#tblfn3){ref-type="table-fn"}Sub-acute (7 days)4.68 ± 0.173.89 ± 0.17[\*](#tblfn3){ref-type="table-fn"}4.47 ± 0.19[ns](#tblfn4){ref-type="table-fn"}4.29 ± 0.06[\*](#tblfn3){ref-type="table-fn"}Sub-acute (14 days)4.89 ± 0.413.78 ± 0.08[\*](#tblfn3){ref-type="table-fn"}4.87 ± 0.17[ns](#tblfn4){ref-type="table-fn"}4.67 ± 0.07[ns](#tblfn4){ref-type="table-fn"}Sub-acute (14 days)4.87 ± 0.393.69 ± 0.07[\*](#tblfn3){ref-type="table-fn"}4.89 ± 0.21[ns](#tblfn4){ref-type="table-fn"}4.69 ± 0.08[ns](#tblfn4){ref-type="table-fn"}  Globulin (g/dL)Acute (1 day)4.09 ± 0.093.98 ± 0.01[\*](#tblfn3){ref-type="table-fn"}4.17 ± 0.09[ns](#tblfn4){ref-type="table-fn"}4.49 ± 0.09[ns](#tblfn4){ref-type="table-fn"}Sub-Acute (7 days)3.89 ± 0.093.19 ± 0.03[\*](#tblfn3){ref-type="table-fn"}4.08 ± 0.008[ns](#tblfn4){ref-type="table-fn"}4.27 ± 0.009[ns](#tblfn4){ref-type="table-fn"}Sub-acute (14 days)4.17 ± 0.082.81 ± 0.03[\*](#tblfn3){ref-type="table-fn"}4.27 ± 0.07[ns](#tblfn4){ref-type="table-fn"}4.28 ± 0.09[ns](#tblfn4){ref-type="table-fn"}Sub-acute (14 days)4.08 ± 0.052.87 ± 0.02[\*](#tblfn3){ref-type="table-fn"}4.29 ± 0.05[ns](#tblfn4){ref-type="table-fn"}4.63 ± 0.03[ns](#tblfn4){ref-type="table-fn"}  A/G ratioAcute (1 day)2.34 ± 0.022.09 ± 0.01[\*](#tblfn3){ref-type="table-fn"}2.21 ± 0.04[ns](#tblfn4){ref-type="table-fn"}2.13 ± 0.02[ns](#tblfn4){ref-type="table-fn"}Sub-acute (7 days)2.41 ± 0.042.64 ± 0.03[\*](#tblfn3){ref-type="table-fn"}2.38 ± 0.03[ns](#tblfn4){ref-type="table-fn"}2.42 ± 0.09[ns](#tblfn4){ref-type="table-fn"}Sub-acute (14 days)2.09 ± 0.032.24 ± 0.18[\*](#tblfn3){ref-type="table-fn"}2.09 ± 0.03[ns](#tblfn4){ref-type="table-fn"}2.12 ± 0.05[ns](#tblfn4){ref-type="table-fn"}Sub-acute (14 days)2.11 ± 0.042.63 ± 0.04[\*](#tblfn3){ref-type="table-fn"}2.18 ± 0.01[ns](#tblfn4){ref-type="table-fn"}2.09 ± 0.03[ns](#tblfn4){ref-type="table-fn"}[^3][^4]Fig. 1(A--D): Histomicrograph (100×) of kidney of *Rattus norvegicus.* A: Control; B: Cadmium treated; C: Catharanthus treated; D: Catharanthus + Cadmium treated. Where Gl (Glomerulus); Tu (Tubules); InTs (Inter-Tubular spaces).

4. Discussion {#s0020}
=============

The results of the study are in agreement with [@b0005]. Since liver and kidneys are the first organ in the body to encounter with cadmium thus most studies of cadmium are centered on detection of early sign of renal dysfunction. Once absorbed from GIT, cadmium forms durable combination with thionein protein in the liver, now called as metallothionien, which play an important in further metabolism of this metal. This is eliminated *via* kidney ([@b0080], [@b0100]).

Serum nitrogenous waste concentration is determined largely by efficiency of renal clearance say glomerular filtration rate \[GFR\] ([@b0020], [@b0060]). The metal accumulated in renal cortex may result in reduced renal clearance ([@b0055]). Accumulation also causes cellular depolarization thus imbalanced flux of sodium and potassium ion resulting in to loss of tubular function. Cadmium may also bind to proteins of filtration membrane causing tubular proteinuria. Cadmium increases sodium reabsorption, decreases cell membrane resistance and stimulates potassium channels ([@b0045], [@b0075]). Cadmium interferes with glomerular filtration rate and tubular re-absorption from any of these possible ways leading to increased serum concentration of nitrogenous wastes and decreased protein profile. The same is shown by comparison of [Fig. 1](#f0005){ref-type="fig"}(A & B). Serum proteinuria might be the possible reason for significant reduction in serum proteins. Proteinuria is the major outcome of oxidative stress produced by cadmium exposure.

GC--MS analysis of *Catharanthus roseus* reveals that terpenoids and phenylpropanoids are its major ingredients, similar finding are observed by [@b0070]. Both of these groups of compounds are well known for their antioxidant property, which compensate with oxidative damage produced by cadmium ([@b0010]). This may overcome significantly glomerular endothelial and tubular injury and provide an extra support to endogenous protection mechanism. This pretreatment with *Catharanthus roseus* extract causes significant retention of serum nitrogenous wastes and protein profiles to normalcy. This ameliorative potential of *Catharanthus roseus* extract is further validated by comparative study of [Fig. 1](#f0005){ref-type="fig"}(A & D).

5. Conclusions {#s0025}
==============

*Catharanthus roseus* extract significantly brought back the changes in renal functions made by cadmium to normalcy. Further separation of extract ingredients and their individual effect studies are proposed. The study was performed in lab animals; further clinical trial is required to establish its utility to human being.
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[^1]: p \< 0.01 significant Vs control.

[^2]: p \> 0.01 non-significant Vs control.

[^3]: p \< 0.01 significant Vs control.

[^4]: p \> 0.01 non-significant Vs control.
